Published in Proc Natl Acad Sci U S A on April 01, 1981
Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell (1997) 2.78
Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci U S A (1995) 2.36
Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci U S A (1986) 2.00
Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol (1982) 1.91
Gut mucosal mast cells. Origin, traffic, and differentiation. J Exp Med (1984) 1.61
Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Natl Acad Sci U S A (1985) 1.60
Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med (1992) 1.56
IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med (1983) 1.56
Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells. Proc Natl Acad Sci U S A (1983) 1.44
Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol (2009) 1.39
Structural, expression, and evolutionary analysis of mouse CIAS1. Gene (2004) 1.33
Stimulation of mucosal mast cell growth in normal and nude rat bone marrow cultures. Proc Natl Acad Sci U S A (1983) 1.32
Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc Natl Acad Sci U S A (1982) 1.30
Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/Wv mice that are genetically deficient in mast cells. J Exp Med (1987) 1.29
Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3. Mol Cell Biol (1985) 1.20
3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency. Proc Natl Acad Sci U S A (1988) 1.18
Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J Exp Med (2011) 1.13
Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA. Proc Natl Acad Sci U S A (1989) 1.12
A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. Proc Natl Acad Sci U S A (1986) 1.12
Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A (1984) 1.11
Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 1.08
Mast cell chemotaxis - chemoattractants and signaling pathways. Front Immunol (2012) 1.07
Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci U S A (1988) 1.07
Proliferation of peritoneal mast cells in the skin of W/Wv mice that genetically lack mast cells. J Exp Med (1984) 1.04
Intestinal mucosal mast cells: isolation from rat lamina propria and purification using unit gravity velocity sedimentation. Immunology (1985) 1.03
Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol (2004) 1.00
Mast cell progenitor trafficking and maturation. Adv Exp Med Biol (2011) 0.98
Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol Cell Biol (2003) 0.94
Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions. J Exp Med (1996) 0.93
Two classes of mouse mast cells delineated by monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 0.92
Antigen-induced, IgE-mediated degranulation of cloned immature mast cells derived from normal mice. Am J Pathol (1987) 0.92
Selective growth of a population of human basophil cells in vitro. Proc Natl Acad Sci U S A (1981) 0.91
Effect of a Trichinella spiralis infection on the distribution of mast cell precursors in tissues of thymus-bearing and non-thymus-bearing (nude) mice determined by an in vitro assay. Immunology (1987) 0.90
Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol (2014) 0.90
Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin. Proc Natl Acad Sci U S A (1985) 0.90
Histamine and chondroitin sulfate E proteoglycan released by cultured human colonic mucosa: indication for possible presence of E mast cells. Proc Natl Acad Sci U S A (1986) 0.90
In vitro studies on mast cell proliferation in N. brasiliensis infection. Immunology (1984) 0.88
Mast cell differentiation depends on T cells and granule synthesis on fibroblasts. Immunology (1983) 0.87
Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response. Infect Immun (2009) 0.85
Microphthalmia transcription factor isoforms in mast cells and the heart. Mol Cell Biol (2007) 0.85
Inhibitory effect of hot-water extract of quince (Cydonia oblonga) on immunoglobulin E-dependent late-phase immune reactions of mast cells. Cytotechnology (2011) 0.82
Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology (2001) 0.81
FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology (1999) 0.81
Effects of IL-3 and SCF on Histamine Production Kinetics and Cell Phenotype in Rat Bone Marrow-derived Mast Cells. Immune Netw (2010) 0.80
Human gastric mucosal mast cells are chondroitin sulphate E-containing mast cells. Immunology (1987) 0.80
Growth of human basophil lines derived from chronic myelocytic leukaemia cells in vitro: ultrastructure and X-ray microanalysis studies. Immunology (1985) 0.79
Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation. Immunology (1998) 0.79
The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. Cell Commun Signal (2013) 0.79
A crucial door to the mast cell mystery knocked in. J Immunol (2009) 0.78
Biosynthesis of paf-acether. Activators of protein kinase C stimulate cultured mast cell acetyltransferase without stimulating paf-acether synthesis. Biochem J (1990) 0.78
LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP. Cell Signal (2013) 0.77
Generation of mast cells from mouse fetus: analysis of differentiation and functionality, and transcriptome profiling using next generation sequencer. PLoS One (2013) 0.76
Conditioned medium from concanavalin A-stimulated spleen cells inhibits the IgE-dependent sensitization of murine peritoneal mast cells in vitro. Immunology (1990) 0.75
Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells. Immunology (1988) 0.75
Number and affinity of receptors for IgE on enriched populations of isolated rat intestinal mast cells. Immunology (1985) 0.75
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Three classes and four (sub)classes of rat immunoglobulins: IgM, IgA, IgE and IgG1, IgG2a, IgG2b, IgG2c. Eur J Immunol (1974) 3.86
The interaction of IgE with rat basophilic leukemia cells. II. Quantitative aspects of the binding reaction. J Exp Med (1974) 3.33
The in vitro differentiation of mast cells. Cultures of cells from immunized mouse lymph nodes and thoracic duct lymph on fibroblast monolayers. J Cell Biol (1967) 3.14
Decreased production of mast cells in S1/S1d anemic mice. Blood (1979) 2.53
FORMATION OF PURE SUSPENSIONS OF MAST CELLS IN TISSUE CULTURE BY DIFFERENTIATION OF LYMPHOID CELLS FROM THE MOUSE THYMUS. J Natl Cancer Inst (1963) 2.04
A modified fluorometric procedure for tissue histamine and its distribution in various animals. J Pharmacol Exp Ther (1969) 1.86
Development of mast cells from grafted bone marrow cells in irradiated mice. Nature (1977) 1.78
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. J Immunol (1976) 1.74
Binding parameters of the interaction between rat IgE and rat mast cell receptors. J Immunol (1975) 1.55
Development of mast cells in vitro. II. Biologic function of cultured mast cells. J Immunol (1977) 1.48
Differentiation and activity of mast cells following immunization in cultures of lymph-node cells. Immunology (1978) 1.46
Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice. J Exp Med (1979) 1.41
The probable relationship of some or all mast cells to the T-cell system. Cell Immunol (1977) 1.40
Basophil activation by concanavalin A: characteristics of the reaction. J Immunol (1974) 1.13
Presence of mast cell precursors in fetal liver of mice. Dev Biol (1979) 1.09
Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis. Blood (1979) 1.07
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet (2001) 5.92
Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41
Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res (1997) 4.05
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89
Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol (1984) 2.85
Genetic alterations in bladder cancer. Lancet (1993) 2.73
Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med (1997) 2.71
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66
Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64
Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci U S A (1999) 2.58
The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell (1991) 2.56
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52
Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene (1990) 2.50
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res (2001) 2.48
A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37
Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36
Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35
NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32
Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31
Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31
Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst (1995) 2.25
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med (1997) 2.21
Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest (2001) 2.20
Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell (1998) 2.18
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A (1985) 2.14
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res (1993) 2.14
Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. J Biol Chem (1982) 2.13
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. Int J Cancer (1997) 2.13
Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol (1987) 2.04
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 2.02
Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99
Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96
Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94
Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94
Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91
Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res (1990) 1.90
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res (2000) 1.87
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
Expression of ras proto-oncogene proteins in normal human tissues. Oncogene (1987) 1.86
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin Chem (2000) 1.85
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res (2000) 1.85
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (1998) 1.82
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79
Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77
Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76